| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P356 | DOI | 10.1002/JBMR.2406 |
| P698 | PubMed publication ID | 25400209 |
| P50 | author | Maria Fusaro | Q46906636 |
| Angela M. Cheung | Q48657503 | ||
| Lisa Langsetmo | Q53843528 | ||
| Charmaine Lok | Q95947550 | ||
| P2093 | author name string | Ron Wald | |
| Eva Szabo | |||
| Sophie A Jamal | |||
| Sarah L West | |||
| Dawn Pearce | |||
| Jordan Weinstein | |||
| P2860 | cites work | A new equation to estimate glomerular filtration rate | Q24651973 |
| Chronic kidney disease and bone fracture: a growing concern | Q34069692 | ||
| Bone mass and microarchitecture in CKD patients with fracture | Q34124155 | ||
| A method of comparing the areas under receiver operating characteristic curves derived from the same cases | Q34272510 | ||
| Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures | Q34580387 | ||
| Discriminants of prevalent fractures in chronic kidney disease | Q35142758 | ||
| The effect of raloxifene treatment in postmenopausal women with CKD. | Q36736747 | ||
| Rapid cortical bone loss in patients with chronic kidney disease | Q37038633 | ||
| BMD, clinical risk factors and their combination for hip fracture prevention | Q43515921 | ||
| Vertebral fracture assessment using a semiquantitative technique. | Q45969757 | ||
| Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials | Q46809656 | ||
| Comparing the areas under more than two independent ROC curves. | Q52593186 | ||
| Cortical pQCT measures are associated with fractures in dialysis patients. | Q53543744 | ||
| Guidelines for diagnosis and management of osteoporosis | Q56888506 | ||
| Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial | Q58216569 | ||
| Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease | Q58311248 | ||
| Effects of denosumab on fracture and bone mineral density by level of kidney function | Q58970644 | ||
| P433 | issue | 5 | |
| P921 | main subject | bone fracture | Q68833 |
| chronic renal insufficiency | Q736715 | ||
| P304 | page(s) | 913-919 | |
| P577 | publication date | 2015-04-16 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | Bone Mineral Density Predicts Fractures in Chronic Kidney Disease | |
| P478 | volume | 30 |
| Q92346687 | 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report |
| Q38802187 | A Comparison of Peripheral Imaging Technologies for Bone and Muscle Quantification: a Mixed Methods Clinical Review. |
| Q30313255 | A comparative study of bone biopsies from the iliac crest, the tibial bone, and the lumbar spine |
| Q92489822 | A multi-imaging modality study of bone density, bone structure and the muscle - bone unit in end-stage renal disease |
| Q96129962 | Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark |
| Q88727827 | Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis |
| Q93032244 | Assessing bone mineralisation in children with chronic kidney disease: what clinical and research tools are available? |
| Q92997985 | Association of Bone Mineral Density With Fractures Across the Spectrum of Chronic Kidney Disease: The Regina CKD-MBD Study |
| Q36195181 | Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study |
| Q38958627 | Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. |
| Q38579166 | Bone Disorders in Chronic Kidney Disease: An Update in Diagnosis and Management |
| Q102221391 | Bone Fragility Fractures in CKD Patients |
| Q57289375 | Bone Health in Chronic Kidney Disease-Mineral and Bone Disorder A Clinical Case Seminar and Update |
| Q30234636 | Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics. |
| Q47738927 | Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. |
| Q91831296 | Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society |
| Q38544166 | Bone kidney interactions |
| Q92748898 | Bone material strength index is associated with prior fracture in men with and without moderate chronic kidney disease |
| Q98226294 | Bone microarchitecture in patients undergoing parathyroidectomy for management of secondary hyperparathyroidism |
| Q92683722 | Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients |
| Q41625862 | Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. |
| Q55378436 | Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism. |
| Q38710364 | Changing bone patterns with progression of chronic kidney disease |
| Q91261545 | Chronic kidney disease is associated with low BMD at the hip but not at the spine |
| Q89901366 | Chronic kidney disease-related osteoporosis is associated with incident frailty among patients with diabetic kidney disease: a propensity score-matched cohort study |
| Q88814822 | Chronic kidney disease: KDIGO CKD-MBD guideline update: evolution in the face of uncertainty |
| Q91641987 | Correlation of Radiomorphometric Indices of the Mandible and Biochemical Parameters in Patients with Secondary Hyperparathyroidism Due to Chronic Kidney Disease |
| Q40457903 | Cortical bone analysis in a predialysis population: a comparison with a dialysis population. |
| Q36281399 | Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture |
| Q91605848 | Cortical unlike trabecular bone loss is not associated with vascular calcification progression in CKD patients |
| Q90064185 | Cost-Effectiveness and Estimated Health Benefits of Treating Patients with Vitamin D in Pre-Dialysis |
| Q49588228 | Dairy product intake and bone properties in 70-year-old men and women. |
| Q49494326 | Declining Hip Fracture Rates in Dialysis Patients: Is This Winning the War? |
| Q36645688 | Diagnosis of low bone mass in CKD-5D patients |
| Q92660881 | Digital radiography as an alternative method in the evaluation of bone density in uremic rats |
| Q88599466 | Effects of parathyroidectomy on bone metabolism in haemodialysis patients with secondary hyperparathyroidism |
| Q38797594 | Emerging role of high-resolution imaging in the detection of renal osteodystrophy. |
| Q100960007 | European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D |
| Q39225909 | Evaluation of fracture risk in chronic kidney disease. |
| Q87850998 | Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis |
| Q99202633 | Executive summary of clinical practice guide on fracture risk in lifestyle diseases |
| Q92021948 | FRAX prognostic and intervention thresholds in the management of major bone fractures in hemodialysis patients: A two-year prospective multicenter cohort study |
| Q91846107 | Fracture status in middle-aged individuals with early CKD: cross-sectional analysis of the CARTaGENE survey |
| Q38518552 | Fractures in chronic kidney disease: pursuing the best screening and management |
| Q61832723 | Fractures in patients with CKD—diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation |
| Q57452989 | Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: a Systematic Review and Meta-Analysis |
| Q90902422 | HR-pQCT Measures of Bone Microarchitecture Predict Fracture: Systematic Review and Meta-Analysis |
| Q91006710 | How and when to assess bone mineral density and bone quality in chronic kidney disease patients? |
| Q38372851 | How to predict and treat increased fracture risk in chronic kidney disease |
| Q89914793 | Imaging of metabolic bone disease |
| Q90288544 | Impact of Recent Clinical Trials on Nephrology Practice: Are We in a Stagnant Era? |
| Q37007559 | In vivo evaluation of bone microstructure in humans: Clinically useful? |
| Q37418997 | Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism |
| Q52674795 | Is there a practical role for a virtual bone biopsy using high-resolution imaging of bone in patients with chronic kidney disease? |
| Q104064896 | KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention and Prevention of Chronic Kidney Disease-Mineral and Bone Disorder (CKDMBD): Indian Commentary |
| Q91189706 | KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) |
| Q49893465 | KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). |
| Q91389038 | Kidney function and its association to imminent, short- and long-term fracture risk-a longitudinal study in older women |
| Q89523882 | Loss of bone mineral density and trabecular bone score in elderly hemodialysis patients: a 2-year follow-up, prospective, single-centre study |
| Q87900128 | Management of Osteoporosis in CKD |
| Q49232902 | Management of Osteoporosis in Chronic Kidney Disease |
| Q88030547 | Menopause in CKD |
| Q97589375 | Metacarpal bone mineral density by radiographic absorptiometry predicts fracture risk in patients undergoing maintenance hemodialysis |
| Q90952462 | Mineral and Bone Disorders After Kidney Transplantation |
| Q38620677 | Mineral metabolism in chronic kidney disease |
| Q30234751 | Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. |
| Q35684700 | Mortality and complications after hip fracture among elderly patients undergoing hemodialysis |
| Q58547302 | Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol |
| Q50917530 | Not only for the risk of bone fracture. |
| Q92902785 | Off-label uses of denosumab in metabolic bone diseases |
| Q99605196 | Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review |
| Q91854872 | Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications |
| Q88497041 | Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations |
| Q39255870 | Osteoporosis, bone mineral density and CKD-MBD: treatment considerations. |
| Q38978628 | Osteoprotegerin and uremic osteoporosis in chronic hemodialysis patients |
| Q57809497 | Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis |
| Q90863076 | Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications |
| Q91162881 | Patients with end-stage kidney disease have markedly abnormal cortical hip parameters by dual-energy X-ray absorptiometry |
| Q90783017 | Personalized Management of Bone and Mineral Disorders and Precision Medicine in End-Stage Kidney Disease |
| Q51744730 | Physical Therapy Considerations for Chronic Kidney Disease and Secondary Sarcopenia. |
| Q39328170 | Positioning novel biologicals in CKD-mineral and bone disorders. |
| Q91060969 | Predictive value of quantitative ultrasound parameters in individuals with chronic kidney disease: A population-based analysis of CARTaGENE |
| Q90994740 | Predictors of bone fractures in a single-centre cohort of hemodialysis patients: a 2-year follow-up study |
| Q39447041 | Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion. |
| Q39008078 | Renal Failure: A Modern Semiology for an Old Disease |
| Q39301592 | Renal Osteodystrophy or Kidney-Induced Osteoporosis? |
| Q57823250 | Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD |
| Q64999355 | Renal involvement in the pathogenesis of mineral and bone disorder in dystrophin-deficient mdx mouse. |
| Q59126536 | Rethinking Bone Disease in Kidney Disease |
| Q57492364 | Review on the Utility of Trabecular Bone Score, a Surrogate of Bone Micro-architecture, in the Chronic Kidney Disease Spectrum and in Kidney Transplant Recipients |
| Q100949629 | Routine serum biomarkers, but not dual-energy X-ray absorptiometry, correlate with cortical bone mineral density in children and young adults with chronic kidney disease |
| Q39220825 | Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies. |
| Q91283386 | The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3-4 CKD |
| Q38836379 | The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives. |
| Q88104814 | The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease |
| Q50124946 | The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease |
| Q88244144 | Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease |
| Q57796694 | Updates in CKD-Associated Osteoporosis |
| Q42370382 | Vitamin D and osteoporosis in chronic kidney disease |
Search more.